Results: << | 101-125 | 126-150 | 151-175 | 176-200 | >>

Table of contents of journal: *Alimentary pharmacology and therapeutics

Results: 176-200/1697

Authors: De Giorgio, R Barbara, G Stanghellini, V Tonini, M Vasina, V Cola, B Corinaldesi, R Biagi, G De Ponti, F
Citation: R. De Giorgio et al., Review article: the pharmacological treatment of acute colonic pseudo-obstruction, ALIM PHARM, 15(11), 2001, pp. 1717-1727

Authors: Edwards, SJ Lind, T Lundell, L
Citation: Sj. Edwards et al., Systematic review of proton pump inhibitors for the acute treatment of reflux oesophagitis, ALIM PHARM, 15(11), 2001, pp. 1729-1736

Authors: Tsang, SWC Chan, HLY Leung, NWY Chau, TN Lai, ST Chan, FKL Sung, JJY
Citation: Swc. Tsang et al., Lamivudine treatment for fulminant hepatic failure due to acute exacerbation of chronic hepatitis B infection, ALIM PHARM, 15(11), 2001, pp. 1737-1744

Authors: Degen, L Matzinger, D Merz, M Appel-Dingemanse, S Osborne, S Luchinger, S Bertold, R Maecke, H Beglinger, C
Citation: L. Degen et al., Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects, ALIM PHARM, 15(11), 2001, pp. 1745-1751

Authors: Capurso, G Lahner, E Marcheggiano, A Caruana, P Carnuccio, A Bordi, C Delle Fave, G Annibale, B
Citation: G. Capurso et al., Involvement of the corporal mucosa and related changes in gastric acid secretion characterize patients with iron deficiency anaemia associated with Helicobacter pylori infection, ALIM PHARM, 15(11), 2001, pp. 1753-1761

Authors: Shiotani, A Saeed, A Yamaoka, Y Osato, MS Klein, PD Graham, DY
Citation: A. Shiotani et al., Citric acid-enhanced Helicobacter pylori urease activity in vivo is unrelated to gastric emptying, ALIM PHARM, 15(11), 2001, pp. 1763-1767

Authors: Williams, D O'Kelly, P Kelly, A Feely, J
Citation: D. Williams et al., Lack of symptom benefit following presumptive Helicobacter pylori eradication therapy in primary care, ALIM PHARM, 15(11), 2001, pp. 1769-1775

Authors: Ikeda, S Tamamuro, T Hamashima, C Asaka, M
Citation: S. Ikeda et al., Evaluation of the cost-effectiveness of Helicobacter pylori eradication triple therapy vs. conventional therapy for ulcers in Japan, ALIM PHARM, 15(11), 2001, pp. 1777-1785

Authors: Laurent, J Megraud, F Flejou, JF Caekaert, A Barthelemy, P
Citation: J. Laurent et al., A randomized comparison of four omeprazole-based triple therapy regimens for the eradication of Helicobacter pylori in patients with non-ulcer dyspepsia, ALIM PHARM, 15(11), 2001, pp. 1787-1793

Authors: Hirschowitz, BI Simmons, J Mohnen, J
Citation: Bi. Hirschowitz et al., Long-term lansoprazole control of gastric acid and pepsin secretion in ZE and non-ZE hypersecretors: a prospective 10-year study, ALIM PHARM, 15(11), 2001, pp. 1795-1806

Authors: Taubel, JJ Sharma, VK Chiu, YL Lukasik, NL Pilmer, BL Pan, WJ
Citation: Jj. Taubel et al., A comparison of simplified lansoprazole suspension administered nasogastrically and pantoprazole administered intravenously: effects on 24-h intragastric pH, ALIM PHARM, 15(11), 2001, pp. 1807-1817

Authors: Geboes, K Dekker, W Mulder, CJJ Nusteling, K
Citation: K. Geboes et al., Long-term lansoprazole treatment for gastro-oesophageal reflux disease: clinical efficacy and influence on gastric mucosa, ALIM PHARM, 15(11), 2001, pp. 1819-1826

Authors: Colpaert, S Liu, Z De Greef, B Rutgeerts, P Ceuppens, JL Geboes, K
Citation: S. Colpaert et al., Effects of anti-tumour necrosis factor, interleukin-10 and antibiotic therapy in the indometacin-induced bowel inflammation rat model, ALIM PHARM, 15(11), 2001, pp. 1827-1836

Authors: Jacob, M Bjarnason, I Rafi, S Wrigglesworth, J Simpson, RJ
Citation: M. Jacob et al., A study of the effects of indometacin on liver mitochondria from rats, mice and humans, ALIM PHARM, 15(11), 2001, pp. 1837-1842

Authors: Rutgeerts, PJ
Citation: Pj. Rutgeerts, Review article: the limitations of corticosteroid therapy in Crohn's disease, ALIM PHARM, 15(10), 2001, pp. 1515-1525

Authors: Buecher, B Bleiberg, H
Citation: B. Buecher et H. Bleiberg, Review article: non-systemic chemotherapy in the treatment of colorectal cancer - portal vein, hepatic arterial and intraperitoneal approaches, ALIM PHARM, 15(10), 2001, pp. 1527-1541

Authors: Guslandi, M
Citation: M. Guslandi, Review article: alternative antibacterial agents for Helicobacter pylori eradication, ALIM PHARM, 15(10), 2001, pp. 1543-1547

Authors: Ragunath, K Williams, JG
Citation: K. Ragunath et Jg. Williams, Review article: balsalazide therapy in ulcerative colitis, ALIM PHARM, 15(10), 2001, pp. 1549-1554

Authors: Corleto, VD Annibale, B Gibril, F Angeletti, S Serrano, J Venzon, DJ Delle Fave, G Jensen, RT
Citation: Vd. Corleto et al., Does the widespread use of proton pump inhibitors mask, complicate and/or delay the diagnosis of Zollinger-Ellison syndrome?, ALIM PHARM, 15(10), 2001, pp. 1555-1561

Authors: Andersson, T Rohss, K Bredberg, E Hassan-Alin, M
Citation: T. Andersson et al., Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole, ALIM PHARM, 15(10), 2001, pp. 1563-1569

Authors: Paul, K Redman, CM Chen, M
Citation: K. Paul et al., Effectiveness and safety of nizatidine, 75 mg, for the relief of episodic heartburn, ALIM PHARM, 15(10), 2001, pp. 1571-1577

Authors: Hamilton, MI Sercombe, J Pounder, RE
Citation: Mi. Hamilton et al., Control of intragastric acidity with over-the-counter doses of ranitidine or famotidine, ALIM PHARM, 15(10), 2001, pp. 1579-1583

Authors: Bardhan, KD Van Rensburg, C
Citation: Kd. Bardhan et C. Van Rensburg, Comparable clinical efficacy and tolerability of 20 mg pantoprazole and 20mg omeprazole in patients with grade I reflux oesophagitis, ALIM PHARM, 15(10), 2001, pp. 1585-1591

Authors: Hawkey, CJ Laine, L Harper, SE Quan, HUI Bolognese, JA Mortensen, E
Citation: Cj. Hawkey et al., Influence of risk factors on endoscopic and clinical ulcers in patients taking rofecoxib or ibuprofen in two randomized controlled trials, ALIM PHARM, 15(10), 2001, pp. 1593-1601

Authors: Talley, NJ Riff, DS Schwartz, H Marcuard, SP
Citation: Nj. Talley et al., Double-blind placebo-controlled multicentre studies of rebamipide, a gastroprotective drug, in the treatment of functional dyspepsia with or without Helicobacter pylori infection, ALIM PHARM, 15(10), 2001, pp. 1603-1611
Risultati: << | 101-125 | 126-150 | 151-175 | 176-200 | >>